Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Xinhua Pharmaceutical is a leading Chinese pharmaceutical company and one of the world's largest manufacturers of antipyretic and analgesic drugs. Established in 1943, the company specializes in the development, manufacture, and sale of chemical bulk drugs (APIs), preparations, and chemical products. It is particularly renowned for its massive production capacity of ibuprofen, aspirin, and caffeine, supplying a significant portion of the global market. The company operates across the entire value chain, from raw material synthesis to finished dosage forms, and maintains a strong presence in both domestic Chinese and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong.